CV · CapsoVision, Inc
$6.55
-0.05 (-0.76%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company, having evaluated the extant facts and circumstances, concluded that the facts and circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of issuance of these financial statements. While the Company raised approximately $14 million in gross proceeds resulting from subsequent Private Placement described in Note 1. DESCRIPTION OF BUSINESS AND ORGANIZATIONAL STRUCTURE and further discussed in Note 9. COMMON STOCK, it is not probable that these funds are sufficient to fund expenditures necessary to achieve sales growth and innovation objectives. The Company intends to consummate additional capital raising activities, but there is no certainty as to such capital raising activities occurring at all, or occurring with sufficient timing or magnitude, sufficient to alleviate such substantial doubt.”View the 10-Q filed May 14, 2026
Market Cap
$324.26M
Shares
49.96M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$13.55M
FY2025
Net Income
-$25.32M
FY2025
Gross Margin
52.92%
FY2025
Operating Margin
-188.25%
FY2025
Diluted EPS
-$1.03
FY2025
Operating Cash Flow
-$22.86M
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 |
|---|---|---|
| $13.56M | $13.55M | |
| $6.56M | $6.38M | |
| $7.01M | $7.17M | |
| — | 52.92% | |
| $19.64M | $18.31M | |
| $7.66M | $7.53M | |
| $6.94M | $6.85M | |
| $220K | $216K | |
| $34.24M | $32.69M | |
| -$27.23M | -$25.52M | |
| — | -188.25% | |
| -$27.01M | -$25.3M | |
| $278K | $225K | |
| -$26.95M | -$25.29M | |
| $24K | $24K | |
| -$26.97M | -$25.32M | |
| — | -186.77% | |
| USD/shares | — | -$1.03 |
| USD/shares | — | -$1.03 |
| shares | — | 24.56M |
| shares | — | 24.56M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.03×
P/E (TTM)
4.95×
Medical Devices median 27.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| United States | $10,657,000 | $9,082,000 |
| Non Us | $2,897,000 | $2,674,000 |
| France | $1,248,000 | $1,160,000 |
| Germany | $598,000 | $565,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Product | $14,484,000 | $12,701,000 |
| Service | $916,000 | $780,000 |